Holen Sie sich die Stockscreener-App
2.745
12.40%
0.245
Schlusskurs vom Vortag:
$2.50
Offen:
$2.52
24-Stunden-Volumen:
7,128
Relative Volume:
0.18
Marktkapitalisierung:
$102.16M
Einnahmen:
$24.38M
Nettoeinkommen (Verlust:
$-53.95M
KGV:
-1.1113
EPS:
-2.47
Netto-Cashflow:
$-23.31M
1W Leistung:
+8.08%
1M Leistung:
-14.33%
6M Leistung:
-26.25%
1J Leistung:
-8.77%
1-Tages-Spanne:
$2.52
$2.77
1-Wochen-Bereich:
$2.4721
$2.85
52-Wochen-Spanne:
$2.28
$5.24
Elutia Inc Stock (ELUT) Company Profile
Firmenname
Elutia Inc
Sektor
Branche
Telefon
240-247-1143
Adresse
12510 PROSPERITY DRIVE, SILVER SPRING
Vergleichen Sie ELUT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
2.77 | 102.16M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
131.62 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.58 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
374.08 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.55 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.03 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-11-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-02 | Eingeleitet | Cowen | Outperform |
| 2020-11-02 | Eingeleitet | Piper Sandler | Overweight |
| 2020-11-02 | Eingeleitet | Truist | Buy |
Elutia Inc Aktie (ELUT) Neueste Nachrichten
Elutia Inc. secures deal with Advantus Health Partners By Investing.com - Investing.com South Africa
Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro?? - MarketScreener
Elutia Enters GPO Deal With Advantus Health Partners - MarketScreener
Elutia Inc. secures deal with Advantus Health Partners - Investing.com India
Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™ - The Manila Times
Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro - TradingView
Healthcare Milestone: Elutia Secures 7th GPO Deal for Revolutionary Antibiotic Device - Stock Titan
Elutia publishes new preclinical data in Antibiotics - TipRanks
Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope - The Manila Times
Groundbreaking Clinical Data: Elutia's FDA-Cleared Device Eliminates All Tested Bacteria - Stock Titan
Elutia Files For Mixed Shelf Of Up To $100 MillionSEC Filing -March 18, 2025 at 06:23 am EDT - Marketscreener.com
Elutia stock soars, Anteris falls in medical devices sector By Investing.com - Investing.com South Africa
Elutia stock soars, Anteris falls in medical devices sector - Investing.com India
HighCape Capital buys $1.05 million in Elutia Inc. stock By Investing.com - Investing.com South Africa
HighCape Capital buys $1.05 million in Elutia Inc. stock - Investing.com India
Elutia Inc. sees $1.05 million stock purchase by HighCape entities - Investing.com Australia
Elutia Inc. Reports Strong Demand for EluPro™ - TipRanks
ELUTIA INC. SEC 10-K Report - TradingView
Earnings call transcript: Elutia Q4 2024 misses forecasts, stock drops By Investing.com - Investing.com Australia
Elutia’s (ELUT) “Overweight” Rating Reiterated at Cantor Fitzgerald - Defense World
Earnings call transcript: Elutia Q4 2024 misses forecasts, stock drops - Investing.com India
Elutia Inc (ELUT) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Product Growth ... - Yahoo Finance
Elutia Inc (ELUT) Q4 2024 Earnings Call Highlights: Strategic Pa - GuruFocus.com
Elutia Inc (ELUT) Reports Q4 2024 Earnings: EPS of -$0.25 Meets - GuruFocus.com
Elutia reports Q4 EPS (26c) vs. (40c) last year - TipRanks
Elutia Inc. Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out - The Manila Times
Can Elutia's EluPro Success Overcome Broader Revenue Challenges? Q4 Earnings Deep Dive - StockTitan
Earnings To Watch: Elutia Inc (ELUT) Reports Q4 2024 Result - GuruFocus.com
Elutia Inc. (NASDAQ:ELUT) Short Interest Update - Defense World
Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025 - The Manila Times
Elutia Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - Nasdaq
Elutia Inc. secures $15 million through stock and warrant sale By Investing.com - Investing.com Nigeria
Elutia’s $15 Million Registered Direct Offering - Global Legal Chronicle
Private equity firms are Elutia Inc.'s (NASDAQ:ELUT) biggest owners and were hit after market cap dropped US$3.9m - Yahoo Finance
Elutia (NASDAQ: ELUT) Preparing to Release 2024 Financial Results - Defense World
Aziyo Biologics Announces Strategic Financial Offering - TipRanks
Elutia Inc. (NASDAQ:ELUT) Short Interest Up 29.8% in January - MarketBeat
Elutia Inc. secures $15 million through stock and warrant sale - Investing.com India
Elutia Inc. reports mixed preliminary 2024 financial results By Investing.com - Investing.com Australia
Elutia launches $15M securities offering - MSN
Elutia Announces $15.0 Million Registered Direct Offering - citybiz
Elutia Inc. reports mixed preliminary 2024 financial results - Investing.com India
Elutia to Raise Roughly $15 Million Through Registered Direct Offering -February 03, 2025 at 09:09 am EST - Marketscreener.com
Finanzdaten der Elutia Inc-Aktie (ELUT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Elutia Inc-Aktie (ELUT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| HighCape Capital, L.P. | Director |
Feb 03 '25 |
Buy |
2.50 |
420,000 |
1,050,000 |
9,520,232 |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER |
Jul 31 '24 |
Option Exercise |
1.43 |
105,080 |
150,002 |
257,823 |
0.76%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):